How do you manage elderly women with high-risk HER2 positive disease with baseline low ejection fraction?

Aside from avoiding use of an anthracycline, I would treat them with a chemotherapy regimen appropriate to their disease stage and overall medical condition - which may mean using a less intensive or shorter regimen than I would in a younger, fit patient with the same stage of HER2+ disease - plus t...